Protection of Proanthocyanidins Against HSP Serum-Induced Inflammation and Oxidative Stress on Human Umbilical Vein Endothelial Cells
Lumei Liu,Meng Wang,Menglu Guo,Li Xian,Jixiang Xu,Dehai Xian,Jianqiao Zhong
DOI: https://doi.org/10.2147/ccid.s440399
2024-03-24
Clinical Cosmetic and Investigational Dermatology
Abstract:Lumei Liu, 1, &ast Meng Wang, 1, &ast Menglu Guo, 2, &ast Li Xian, 3, &ast Jixiang Xu, 1 Dehai Xian, 4 Jianqiao Zhong 1 1 Department of Dermatology, the Affiliated Hospital, Southwest Medical University, Luzhou, 646000, People's Republic of China; 2 Department of Dermatology, the People's Hospital of Leshan, Southwest Medical University, Leshan, 614003, People's Republic of China; 3 Department of Emergency, the Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China; 4 Department of Neurobiology, Southwest Medical University, Luzhou, 646000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jianqiao Zhong, Department of Dermatology, the Affiliated Hospital, Southwest Medical University, No. 25 Tai Ping Jie, Luzhou, Sichuan, 646000, People's Republic of China, Tel +86-15082088598, Fax +86-830-3198173, Email Dehai Xian, Department of Neurobiology, Southwest Medical University, Luzhou, 646000, People's Republic of China, Tel +86-18008203056, Email Background: Immune-mediated inflammation and oxidative stress play pivotal roles in Henoch-Schonlein purpura (HSP), primarily through the TLR4/MyD88/NF-κB pathway. Proanthocyanidins (PCs) exert anti-inflammatory and antioxidant effects by regulating some signals like TLR4/MyD88/NF-κB. Previous research uncovered that PCs could alleviate purpura-like lesions and pathological changes on rats likely through attenuating inflammation and OS damage. The mechanism of PCs on HSP deserves further investigation. Objective: To clarify the potential mechanism of PCs to HUVECs induced by the serum of HSP patients. Methods: HUVECs were randomly divided into blank, control, model, and low-, medium-, and high-concentration PCs group. Then, 25% HSP serum was assigned to the latter four groups, while 25% serum from healthy subjects to control group and serum-free culture medium to blank one. The last three groups separately received different concentrations of PCs. In addition, TAK-242, a TLR4 inhibitor, was applied to investigate the effect of TLR4-related signals in PCs against HSP serum-induced damage. Finally, inflammatory and OS-related parameters were detected by using cytological/molecular-biological techniques. Results: Treated with HSP serum later, the levels of immuno-inflammatory and oxidative indicators obviously went up (P < 0.05), and those of antioxidants remarkably went down (P < 0.05). PCs, however, reversed above phenomena (P < 0.05). Moreover, TLR4, MyD88 and NF-κB proteins/genes highly expressed in the model group; but significantly fell off in the presence of PCs (P 0.05). These alterations likewise occurred after TAK-242 pretreatment with or without PCs, ie a notable drop of TLR4, MyD88 and NF-κB appeared in TAK-242 presence, few differences existing when compared to the PCs groups. Conclusion: PCs effectively protect HUVECs from inflammatory and OS damage provoked by HSP serum via blocking TLR4/MyD88/NF-κB signals. Keywords: proanthocyanidins, Henoch-schönlein purpura, TLR4/MyD88/NF-κB, inflammation, oxidative stress Henoch-Schönlein purpura (HSP) is a common, immune-mediated, systemic small vessel vasculitis, frequently occurring in childhood with a high recurrence rate. In histopathology, it typically manifests as leukocytoclastic vasculitis and deposition of capillary immunoglobulin (Ig)A immune complexes. 1,2 HSP causes various symptoms in different organs, especially preferring the skin, joints, gastrointestinal tract and kidneys, which tends to prejudice the pediatric well-being. 3,4 At present, many therapeutic vehicles are available for HSP, such as vitamin C, calcium, corticosteroids, immunosuppressant (eg mycophenolate mofetil or cyclosporine), and so on; but most of them stand still due to their transient efficacy or undesirable reactions or recurrent troubles or high cost. 5,6 So far, few treatments seem satisfactory for this condition. Consequently, a safe, effective and affordable approach is urgently needed. Although the pathogenesis of HSP have not been fully elucidated, it is currently considered that immune inflammation and oxidative stress (OS) get deeply involved in it, especially the activation of toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear transcription factor-kappa B (NF-κB) signaling way. 7–10 TLR4 is a key transmembrane protein mediating the inflammatory a -Abstract Truncated-
dermatology